 1. Assess the effectiveness of maternal supplementation with Docosahexaenoic acid DHA early in pregnancy to reduce the incidence of deep placentation disorders: preterm birth, preterm labor, preterm premature rupture of membranes, preeclampsia and fetal growth restriction. 